Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
Where this comes from
- Record sourced from PubMed, PMID 32420631.
- Also identified by DOI 10.1002/hed.26256 and PMC identifier 7276867.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2019 Coronavirus Pandemic challenges the delivery of care for patients with head and neck cancer. An important aspect of this care has been the evolution of enhanced survivorship services, which include surveillance for recurring cancer and prevention of second primaries. The application of evidence-based approaches to the identification and management of treatment and tumor-related toxicities has embraced the use of validated patient-reported outcomes instruments, health promotion, and care coordination. In this manuscript, we describe how our multidisciplinary team of survivorship providers has accommodated to the need to provide patients with social distancing while acknowledging the importance of continued care during treatment and through the spectrum of survivorship.
Medical subject headings
- Betacoronavirus
- Continuity of Patient Care
- Coronavirus Infections
- Head and Neck Neoplasms
- Patient Care Team
- Pneumonia, Viral
- Survivorship